During a seminar with the Rutgers cohort of 25 young African leaders, institute director Richard Marlink led a discussion about mobilizing three essential strategies to end the epidemic: follow the science, treat the whole person, and expand the health care workforce.
Programs to prevent HIV in transgender women are helping to lower the rate of new infection, but better care and treatment of this vulnerable population are still needed, especially among those with lower income or people of color, according to a study led by core faculty member Henry Raymond, an associate professor at the School of Public Health.
Rutgers professor and pediatric infectious diseases expert Glenn Fennelly is featured in a five-part Contagion video series about measles. He discusses vaccination, individual state laws, exemption definitions, and the role clinicians and public health officials play in these measles outbreaks. Christina Tan, an assistant commissioner of health for New Jersey, is also featured.
Tuberculosis researcher Christopher Vinnard of Rutgers’ Public Health Research Institute is developing a urine test that can pinpoint—easily and resourcefully—the effectiveness of patients’ TB treatment dosages. This new test would be more accessible to clinicians in low-income countries.
Healio.com’s Infectious Disease News spoke with institute director Richard Marlink, MD, who treated some of the first HIV/AIDS patients at St. Vincent’s Hospital in New York and helped establish the first HIV/AIDS clinic in Boston. In this interview marking the 30th anniversary of World AIDS Day, Marlink discusses the likelihood of a cure and vaccine, federal funding, testing among high-risk populations, PrEP, stigma, and medical treatment.